申请人:AGIOS PHARMACEUTICALS, INC
公开号:US10087172B2
公开(公告)日:2018-10-02
Provided are compounds of formula (I), which can inhibit glutaminase. Pharmaceutical compositions comprising these compounds and uses as glutaminase inhibitors for treating cancers thereof are also provided.
提供了可抑制谷氨酰胺酶的式 (I) 化合物。还提供了包含这些化合物的药物组合物以及作为谷氨酰胺酶抑制剂治疗癌症的用途。